Caspian Oliai, MD, MS, medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center, discusses ...

A new article outlines a new tool that measures blood inflammation as a marker for poor CAR T therapy outcomes.

Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 ...

Cancer Center have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient's likely response ...

Bispecific antibodies have become component in the arsenal of treatments for hematologic malignancies; management of their side effects is crucial to their success.

Scientists have supercharged CAR-T therapy, making it more powerful against elusive cancer cells that usually escape detection. This innovation, called ALA-CART, helps the immune system better ...

It develops from the abnormal multiplication of T cells ... if the lymphoma has spread to the central nervous system Tests for various viruses including HIV, HTLV-1, and Epstein-Barr virus ...

Herpesvirus-encoded microRNAs (v-miRNAs) play a crucial role in modulating host cellular processes to promote viral persistence, immune evasion, and pathogenesis. These v-miRNAs function by targeting ...